Orange County Business Journal

Generic Drug Maker Sicor Looks to Biotech for More Growth

Orange County isn’t readily associated with drug companies to the same degree that its southern neighbor San Diego is. But Irvine’s Sicor Inc. is raising the county’s drug-making profile. Sicor, a ...
Orange County Business Journal

Generic drug maker Sicor Inc. has as much work for lawyers as for researchers

Several big conventional and biotechnology drugs are set to lose patent protection in the next few years,creating a potential bonanza for generic drug makers. Irvine-based Sicor Inc., for one, is ...
Los Angeles Times

Sicor Plans Large Stock Offering to Raise Capital

Sicor Inc. plans to sell 20 million shares of common stock in a secondary offering, according to regulatory documents filed Friday. The Irvine company, which makes generic drugs, plans to offer 10 ...
Los Angeles Times

Drug Maker Teva to Buy Sicor

In a bid to boost sales of its generic drugs to U.S. hospitals, Israel’s Teva Pharmaceutical Industries Ltd. said Friday that it would buy Irvine-based pharmaceuticals maker Sicor Inc. for $3.4 ...
MarketWatch

Sicor rallies on approval of generic fludarabine

NEW YORK (CBS.MW) -- Shares of Sicor rallied $1.89, or 9.9 percent, to $20.95 in pre-open trading after pharmaceutical company said late Thursday its fludarabine phosphate for injection, a treatment ...
Wall Street Journal

Generic-Drug Maker Teva To Buy Sicor for $3.33 Billion

Teva Pharmaceutical Industries Ltd., a large generic-drug company, has agreed to acquire Sicor Inc. for $3.33 billion in cash and stock, or $27.35 per share, in a bid to move into generic injectable ...